Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study yesterday.
Presenting the findings at the European Society of Cardiology’s annual meeting in London, they said the study showed for the first time that blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the following three decades.
“This is good for patients first and foremost, but it is also important information for [manufacturers of] cholesterol lowering drugs, anti-inflammatory drugs and lipoprotein(a)-lowering drugs — the implications for therapy are broad,” said Paul Ridker of Brigham and Women’s Hospital in Boston, the study leader.
Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data ... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of five or 10 year risk.”
The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.
They also had tests for high-sensitivity C-reactive protein (hsCRP) — a marker of blood vessel inflammation — and lipoprotein(a), a genetically determined type of fat.
Compared with risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the following 30 years were 36 percent higher in women with the highest levels of LDL-C, 70 percent higher in women with the highest levels of hsCRP and 33 percent higher in those with the highest levels of lipoprotein(a).
Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the following three decades, said a report of the study in The New England Journal of Medicine that was published to coincide with the presentation at the meeting.
“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said. “The therapies we might use in response to an elevation in each biomarker are markedly different and physicians can now specifically target the individual person’s biologic problem.”
While drugs that lower LDL-C and hsCRP are widely available — including statins, and pills for high blood pressure and heart failure — drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis, Amgen, Eli Lilly and London-based Silence Therapeutics.
Lifestyle changes such as exercising and quitting smoking can also be helpful.
Most of the women in the study were white Americans, but the findings would likely “have even greater impact among black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.
“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”
POLITICAL PRISONERS VS DEPORTEES: Venezuela’s prosecutor’s office slammed the call by El Salvador’s leader, accusing him of crimes against humanity Salvadoran President Nayib Bukele on Sunday proposed carrying out a prisoner swap with Venezuela, suggesting he would exchange Venezuelan deportees from the US his government has kept imprisoned for what he called “political prisoners” in Venezuela. In a post on X, directed at Venezuelan President Nicolas Maduro, Bukele listed off a number of family members of high-level opposition figures in Venezuela, journalists and activists detained during the South American government’s electoral crackdown last year. “The only reason they are imprisoned is for having opposed you and your electoral fraud,” he wrote to Maduro. “However, I want to propose a humanitarian agreement that
ECONOMIC WORRIES: The ruling PAP faces voters amid concerns that the city-state faces the possibility of a recession and job losses amid Washington’s tariffs Singapore yesterday finalized contestants for its general election on Saturday next week, with the ruling People’s Action Party (PAP) fielding 32 new candidates in the biggest refresh of the party that has ruled the city-state since independence in 1965. The move follows a pledge by Singaporean Prime Minister Lawrence Wong (黃循財), who took office last year and assumed the PAP leadership, to “bring in new blood, new ideas and new energy” to steer the country of 6 million people. His latest shake-up beats that of predecessors Lee Hsien Loong (李顯龍) and Goh Chok Tong (吳作棟), who replaced 24 and 11 politicians respectively
Young women standing idly around a park in Tokyo’s west suggest that a giant statue of Godzilla is not the only attraction for a record number of foreign tourists. Their faces lit by the cold glow of their phones, the women lining Okubo Park are evidence that sex tourism has developed as a dark flipside to the bustling Kabukicho nightlife district. Increasing numbers of foreign men are flocking to the area after seeing videos on social media. One of the women said that the area near Kabukicho, where Godzilla rumbles and belches smoke atop a cinema, has become a “real
‘WATER WARFARE’: A Pakistani official called India’s suspension of a 65-year-old treaty on the sharing of waters from the Indus River ‘a cowardly, illegal move’ Pakistan yesterday canceled visas for Indian nationals, closed its airspace for all Indian-owned or operated airlines, and suspended all trade with India, including to and from any third country. The retaliatory measures follow India’s decision to suspend visas for Pakistani nationals in the aftermath of a deadly attack by shooters in Kashmir that killed 26 people, mostly tourists. The rare attack on civilians shocked and outraged India and prompted calls for action against their country’s archenemy, Pakistan. New Delhi did not publicly produce evidence connecting the attack to its neighbor, but said it had “cross-border” links to Pakistan. Pakistan denied any connection to